Department of Surgery, Oulu University Hospital, Oulu, Finland.
J Cardiothorac Vasc Anesth. 2013 Apr;27(2):213-9. doi: 10.1053/j.jvca.2012.11.007.
The authors evaluated the outcome of patients≥80 years undergoing mitral valve (MV) surgery.
Systematic review of the literature and meta-analysis.
None.
None.
None.
Twenty-four studies reporting on 5,572 patients ≥80 years of age who underwent MV surgery were included in this analysis. Pooled proportion of operative mortality was 15.0% (95% confidence interval [CI] 11.9-18.1), stroke was 3.9% (95% CI 2.6-5.2), and dialysis was 2.7% (95% CI 0.5-4.9). Early date of study (p = 0.014), increased age (p = 0.006), MV replacement (p = 0.008), procedure other than isolated MV surgery (p = 0.010), MV surgery associated with coronary artery surgery (p = 0.029), aortic cross-clamping time (p<0.001), and cardiopulmonary bypass time (p<0.001) were associated significantly with increased operative mortality. MV repair had lower operative mortality compared with MV replacement (7.3% v 14.2%, relative risk 0.573, 95% CI 0.342-0.962). Random-effects metaregression showed that prolonged aortic cross-clamping time (p = 0.005) was the only determinant of increased operative mortality, even when adjusted (p<0.001) for date of study (p = 0.004). Operative mortality was significantly higher in studies reporting a mean cross-clamp time >90 minutes (17.0% v 7.4%, p<0.001). Survival rates at 1, 3, and 5 years were 76.1%, 67.7%, and 56.5%, respectively.
MV surgery in patients ≥80 years of age is associated with operative mortality, which has decreased significantly during recent years. Prolonged aortic cross-clamp time is a major determinant of operative mortality. MV repair may achieve better results than MV replacement in the very elderly. Five-year survival of these patients is good and justifies surgical treatment of MV diseases in octogenarians.
评估≥80 岁患者行二尖瓣(MV)手术的结果。
文献系统回顾和荟萃分析。
无。
无。
无。
纳入了 24 项研究,共 5572 例≥80 岁行 MV 手术的患者。汇总手术死亡率为 15.0%(95%置信区间 [CI] 11.9-18.1),卒中为 3.9%(95% CI 2.6-5.2),透析为 2.7%(95% CI 0.5-4.9)。早期研究日期(p = 0.014)、年龄增加(p = 0.006)、二尖瓣置换术(p = 0.008)、非孤立二尖瓣手术(p = 0.010)、二尖瓣手术联合冠状动脉旁路手术(p = 0.029)、主动脉阻断时间(p<0.001)和体外循环时间(p<0.001)与手术死亡率显著相关。与二尖瓣置换术相比,二尖瓣修复术的手术死亡率较低(7.3%比 14.2%,相对风险 0.573,95% CI 0.342-0.962)。随机效应荟萃回归显示,只有主动脉阻断时间延长(p = 0.005)是导致手术死亡率增加的唯一决定因素,即使调整了研究日期(p = 0.004)(p<0.001)。报告平均阻断时间>90 分钟的研究中,手术死亡率显著较高(17.0%比 7.4%,p<0.001)。1、3 和 5 年的生存率分别为 76.1%、67.7%和 56.5%。
≥80 岁患者行 MV 手术与手术死亡率相关,近年来死亡率显著下降。主动脉阻断时间延长是手术死亡率的主要决定因素。在非常高龄患者中,二尖瓣修复术可能比二尖瓣置换术获得更好的结果。这些患者的 5 年生存率较好,证明了对 80 岁以上患者行 MV 疾病手术治疗的合理性。